Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Inven2 AS
Entity

Inven2 AS

Tracked across 1 events · 7 articles · First seen Aug 04, 2026 · Last active Aug 10, 2026

Sentiment
10
Attention
1
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
1 10
Business
Zelluna issues shares to Inven2
Zelluna ASA, a biotech company developing TCR-NK cell therapies for solid cancers, issued 446,752 new shares to Inven2 AS at a subscription price of NOK 19.7752 per share, increasing its share capital from NOK 29,413,759…
Impact: Inven2 received 446,752 new shares in Zelluna as settlement for amounts owed under an option and license agreement, becoming a shareholder.
Aug 04, 2026 · 7 articles
Key Actions (1)
80 Zelluna ASA issued shares Inven2 ASZelluna issues shares to Inven2
ERGEN INTELLIGENCE
Track Inven2 AS live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.